Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
Figure 1
Stages of disease progression and intervention in T1D. Progression over time (-axis) from simple genetic susceptibility to β-cell autoimmunity and T1D is plotted against residual β-cell mass (-axis). The time points at which immune therapies are administered are shown in red.